• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific launches nerve stimulation trial | MassDevice.com On Call

Boston Scientific launches nerve stimulation trial | MassDevice.com On Call

September 30, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) enrolled the first patients into the NECTAR-HF clinical study testing chronic vagal nerve stimulation as a therapy for heart failure patients.

“Stimulating the vagus nerve in the cervical region is commonly used to treat epilepsy and depression," principal investigator Dr. Faiez Zannad said in prepared remarks. "[H]owever, promising pre-clinical data show that this therapy may also help a large population of heart failure patients who are currently not candidates for heart failure device therapy."

The first implants in the 96-patient trial were received by patients at Hospital Clinic in Barcelona, Spain, according to the press release.

Supreme Court to consider health care reform challenges

The individual insurance mandate in president Barack Obama’s health care reform law, which has been the subject of legal volleying since it passed, is on its way to the Supreme Court with a petition by 26 state attorneys who want to see the decision made by the nations’ highest court, Healthwatch reported..

Stanford Hospital may pay $20 million for privacy breach

Stanford University Hospital faces a $20 million class action lawsuit over a data breach that revealed private information for 20,000 emergency room patients online for almost a year, Law360.com reported (paid).

Meanwhile, nearly 5 million patient records were exposed by a data breach at Tricare, a health care program for retired military members.

Earliest stages of tumor development revealed

Scientists gained new insight into the earliest stages of tumor development and are looking for ways to stop them from happening, according to a study funded by the National Institutes of Health.

Double balloon enteroscopy proves safe and effective

A large-scale Chinese study of double balloon enteroscopy spanning the last decade showed the procedure to be safe and effective for detecting diseases in the small intestine, according to an American Society for Gastrointestinal Endoscopy press release.

Filed Under: Healthcare Reform, Legal News, News Well, Oncology Tagged With: Boston Scientific, Clinical Trials, Stanford Hospital

More recent news

  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt
  • Penumbra completes enrollment in pulmonary embolism trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy